InsidersTradesSigma
Track the 瑞康医药 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 瑞康医药 has logged 6 reports. Market capitalisation: €4.1bn. The latest transaction was disclosed on 21 June 2024 (Purchase). Among the most active insiders: 张仁华. The full history is free.
6
Insider Decl.
n/a
Thresholds
€772,687
1 ops.
Buy Volume
€28m
5 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,651 of 28,958 companies
23.5
score / 100
Value29
Quality18
FCF yld-0.3%
Earn yld0.4%
EV/EBITDA24.2x
ROE0.8%
Gross mgn11%
Net mgn0.2%
Debt/EBITDA12.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 June 2024
Declarations6 total
2,638,600 sharesA股XSHESZSE:173000007779437440
6 of 6 declarations
About 瑞康医药
瑞康医药 is a company specializing in the healthcare and pharmaceutical sector, providing products and services related to health care. It is listed on the XSHE market.